OBJECTIVE: Pituitary tumor transforming gene (PTTG) is an important paracrine growth factor involved in early lactotrope transformation and early onset of angiogenesis in pituitary hyperplasia. Emerging evidences have shown that PTTG expression may contribute to the etiology of pituitary adenomas; but individually published studies showed inconclusive results. This meta-analysis aimed to derive a more precise estimation of the correlations of PTTG expression with human pituitary adenomas. METHODS: A range of electronic databases were searched: MEDLINE (1966∼2013), the Cochrane Library Database (Issue 12, 2013), EMBASE (1980∼2013), CINAHL (1982∼2013), Web of Science (1945∼2013) and the Chinese Biomedical Database (CBM) (1982∼2013) without la...
Oncogenes and tumor suppressor genes involved in most common cancers are not involved in the great m...
BACKGROUND:The proto-oncogene pituitary tumor-transforming gene (PTTG) has been shown to be abundant...
Pituitary adenomas make up to 10-15% of all intracranial tumors. Pos-mortem exams have found them in...
Objective: Pituitary tumor transforming gene (PTTG) is an important paracrine growth factor involved...
Background: The pituitary tumour transforming gene (pttg) plays a central role in pituitary tumorige...
BACKGROUND: The pituitary tumour transforming gene (pttg) plays a central role in pituitary tumorige...
The purpose of this study was to investigate a) PTTG expression in pituitary adenoma subtypes, b) th...
Abstract Background It has been suggested that pituitary adenoma results from accumulation of multip...
<p>Results were computed by omitting each study in turn. Meta-analysis random-effects estimates (exp...
Summary. Pituitary tumor transforming gene (PTTG) is an oncogene which is found to be highly express...
The pathogenesis of tumour formation in the anterior pituitary has been intensively studied, but the...
Genetic and functional aberrations of guanine nucleotide-binding protein, alpha stimulating (GNAS), ...
Pituitary adenomas, monoclonal in origin, are the most common intracranial neoplasms. Altered gene e...
<p>PAs = pituitary adenomas; M = male; F = female; NOS = Newcastle-Ottawa Scale.</p
The pathological behaviour of pituitary adenomas (PAs) is complex and difficult to predict. In this ...
Oncogenes and tumor suppressor genes involved in most common cancers are not involved in the great m...
BACKGROUND:The proto-oncogene pituitary tumor-transforming gene (PTTG) has been shown to be abundant...
Pituitary adenomas make up to 10-15% of all intracranial tumors. Pos-mortem exams have found them in...
Objective: Pituitary tumor transforming gene (PTTG) is an important paracrine growth factor involved...
Background: The pituitary tumour transforming gene (pttg) plays a central role in pituitary tumorige...
BACKGROUND: The pituitary tumour transforming gene (pttg) plays a central role in pituitary tumorige...
The purpose of this study was to investigate a) PTTG expression in pituitary adenoma subtypes, b) th...
Abstract Background It has been suggested that pituitary adenoma results from accumulation of multip...
<p>Results were computed by omitting each study in turn. Meta-analysis random-effects estimates (exp...
Summary. Pituitary tumor transforming gene (PTTG) is an oncogene which is found to be highly express...
The pathogenesis of tumour formation in the anterior pituitary has been intensively studied, but the...
Genetic and functional aberrations of guanine nucleotide-binding protein, alpha stimulating (GNAS), ...
Pituitary adenomas, monoclonal in origin, are the most common intracranial neoplasms. Altered gene e...
<p>PAs = pituitary adenomas; M = male; F = female; NOS = Newcastle-Ottawa Scale.</p
The pathological behaviour of pituitary adenomas (PAs) is complex and difficult to predict. In this ...
Oncogenes and tumor suppressor genes involved in most common cancers are not involved in the great m...
BACKGROUND:The proto-oncogene pituitary tumor-transforming gene (PTTG) has been shown to be abundant...
Pituitary adenomas make up to 10-15% of all intracranial tumors. Pos-mortem exams have found them in...